Respiratory and cardiovascular effects of the μ-opioid receptor agonist [Lys7]dermorphin in awake rats

British Journal of Pharmacology

Volumn 124, Issue 2, 1998, Pages 345-355

  Negri, Lucia ^a   Lattanzi, Roberta ^a   Tabacco, Fabio ^a   Melchiorri, Pietro ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Awake rats; Blood pressure; Opioids; Respiratory depression; Respiratory stimulation; Lys7 dermorphin

Indexed keywords

17 METHYLNALOXONE BROMIDE; ANALGESIC AGENT; DERMORPHIN; DERMORPHIN DERIVATIVE; DRUG METABOLITE; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALOXONAZINE; NALOXONE; OPIATE RECEPTOR; RITANSERIN; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ANTINOCICEPTION; ARTERIAL PRESSURE; ARTICLE; BREATHING; BREATHING RATE; CARDIOVASCULAR FUNCTION; CATALEPSY; CONTROLLED STUDY; HEART RATE; LUNG MINUTE VOLUME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATION DEPRESSION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031807504     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701823     Document Type: Article

References (51)

1. ANDERSON, I.K., MARTIN, G.R. & RAMAGE, A.G. (1995). Evidence that activation of 5-HT receptors in the forebrain of anaesthetized cats causes sympathoexcitation. Br. J. Pharmacol. 116, 1751-1756.
2. BARTLETT, D. & TENNEY, S.M. (1970). Control of breathing in experimental anemia. Respir. Physiol., 10, 384-395.
3. BIANCHI, A.L., DENAVIT-SAUBIÉ, M. & CHAMPAGNAT, J. (1995). Central control of breathing in mammals: neuronal circuitry, membrane properties and neurotransmitters. Physiol. Rev., 75, 1-45.
4. BONHAM, A.C. (1995). Neurotransmitters in the CNS control of breathing. Respir. Physiol., 101, 219-230.
5. CALIGNANO, A., PERSICO, P., MANCUSO, F. & SORRENTINO, L. (1992). Adenosine release in morphine-induced hypotension in rats. Gen. Pharmacol., 23, 7-10.
6. CAO, B.J. & RODGERS, R.J. (1997). Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN-190. Pharmacol. Biochem. Behav., 58, 593-603.
7. 1A-receptors. Br. J. Pharmacol., 122, 631-638.
8. COLLINSON, N. & DAWSON, G.R. (1997). On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635. Psychopharmacology (Berl)., 132, 35-43.
9. CRAGG, P.A. & DRYSDALE, D.B. (1983). Interaction of hypoxia and hypercapnia on ventilation, tidal volume and respiratory frequency in the anaesthetized rat. J. Physiol., 341, 477-493.
10. CROCI, T., EMONDS-ALT, X., LE FUR, G. & MANARA, L. (1995). In vitro characterization of the non-peptide tachykinin NK1 and NK2-receptor antagonists, SR140333 and SR48968 in different rat and guinea-pig intestinal segments. Life Sci., 56, 267-275.
11. D'AMOUR, F.E. & SMITH, D.L. (1941). Method for determining loss of pain sensation. J. Pharmacol. Exp. Ther., 72, 74-79.
12. DALY, M. DE B. (1986). Interactions between respiration and circulation. In Handbook of Physiology, section 3, The Respiratory System. Vol. 2. ed. Cherniack, N.S. & Widdicombe, J.G. pp. 529-594. Bethesda, MD, U.S.A: American Physiological Society.
13. 2-receptors on rat brainstem neurones. Br. J. Pharmacol., 94, 483-491.
14. EMONDS-ALT, X., DOUTREMEPUICH, J.D., HEALUME, M., NELIAT, G., SANTUCCI, V., STEINBERG, R., VILAIN, P., BICHON, D., DUCOUX, J.P., PROIETTO, V. (1993). In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur. J. Pharmacol., 250, 403-413.
15. EPSTEIN, M.A.F. & EPSTEIN, R.A. (1978). A theoretical analysis of the barometric method for measurement of tidal volume. Respir. Physiol., 32, 105-120.
16. EVANS, A.G.J., NASMYTH, P.A. & STEWART, H.C. (1952). The fall of blood pressure caused by intravenous morphine in the rat and cat. Br. J. Pharmacol., 7, 452-459.
17. 1A receptor antagonist, WAY-100635. Eur. J. Pharmacol., 281, 81-88.
18. JACKSON, H.C., BEARHAM, M.C., HUTCHINS, L.C., MAZURKIEWICZ, S.E., NEEDHAM, A.M. & HEAL, D.J. (1997). Investigation of the mechanism underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br. J. Pharmacol., 121, 1613-1618.
19. 7 receptor (h5-HT7b). Br. J. Pharmacol., 122, 126-132.
20. 1A receptor antagonist. Brain Res., 673, 217-225.
21. KHAWAJA, X., EVANS, N., REILLY, Y., ENNIS, C. & MINCHIN, M.C. (1995). Characterisation of the binding of [3H]WAY-100635, a novel 5-hydroxytryptamine 1A receptor antagonist, to rat brain. J. Neurochem., 64, 2716-2726.
22. KING, K.A. & HOLTMAN, J.R. (1990). Characterization of the effects of activation of ventral medullary serotonin receptor subtypes on cardiovascular activity and respiratory motor outflow to the diaphragm. J. Pharmacol. Exp. Ther., 252, 665-674.
23. (2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. J. Pharmacol. Exp. Ther., 282, 747-759.
24. KOKKA, N., ELLIOTT, H.W. & WAY, E.L. (1965). Some effects of morphine on respiration and metabolism of rats. J. Pharmacol. Exp. Ther., 148, 425-430.
25. LAI, J.L., LAMM, W.J.E. & HILDEBRANDT, J. (1981). Ventilation during prolonged hypercapnia in the rat. J. Appl. Physiol., 51, 78-83.
26. LEMAIRE, J., TSENG, R. & LEMAIRE, S. (1978). Systemic administration of β-endorphin: potent hypotensive effect involving a serotoninergic pathway. Proc. Natl. Acad. Sci. U.S.A., 75, 6240-6242.
27. LINDSAY, A.D. & FELDMAN, J.L. (1993). Modulation of respiratory activity of neonatal rat phrenic motoneurones by serotonin. J. Physiol., 461, 213-233.
28. LING, G.S.F., SPIEGEL, K., LOCKHART, S.H. & PASTERNAK, G.W. (1985). Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms. J. Pharmacol. Exp. Ther., 232, 149-155.
29. LLOYD, B.B., JUKES, M.G.M. & CUNNINGHAM, D.J.C. (1958). The relation between alveolar oxygen pressure and the respiratory response to carbon dioxide in man. Q. J. Exp. Physiol., 43, 214-227.
30. MARTIN, W.R. (1983). Pharmacology of opioids. Pharmacol. Rev., 35, 283-323.
31. MASKREY, M., MEGIRIAN, D. & NICOL, S.C. (1981). Effects of decortication and carotid sinus nerve section on ventilation of the rat. Resp. Physiol., 43, 263-273.
32. MELCHIORRI, P. & NEGRI, L. (1996). The dermorphin peptide family. Gen. Pharmacol., 27, 1099-1107.
33. 2C receptors in learning. Behav. Brain Res., 87, 105-110.
34. 2C receptor subtypes in the two types of fear generated by the elevated T-maze. Pharmacol. Biochem. Behav., 58, 1051-1057.
35. NEGRI, L., FALCONIERI ERSPAMER, G., SEVERINI, C., POTENZA, R.L., MELCHIORRI, P. & ERSPAMER, V. (1992). Dermorphin related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two μ-opioid recpetor subtypes which modulate antinociception and catalepsy, in the rat. Proc. Natl. Acad. Sci. U.S.A., 89, 7203-7207.
36. 7]dermorphin, a naturally occurring peptide with high affinity for μ-opioid receptors, produces antinociception by peripheral administration. Br. J. Pharmacol., 114, 57-66.
37. OLSON, E.B. & DEMPSEY, J.A. (1978). Rat as a model for human like ventilatory adaptation to chronic hypoxia. J. Appl. Physiol., 44, 763-769.
38. 1 receptor-mediated effect. J. Pharmacol. Exp. Ther., 250, 235-240.
39. 1 receptors? J. Pharmacol. Exp. Ther., 266, 544-550.
40. PEROUTKA, S.J. (1993). 5-Hydroxytryptamine receptors. J. Neurochem., 60, 408-416.
41. PITHA, J. IRIE, T., SKLAR, P.B. & NYE, J.S. (1988). Drug solubilizers to aid pharmacologists: amorphous cyclodextrin derivatives. Life Sci., 43, 493-502.
42. RANDICH, A., ROBERTSON, J.D. & WILLINGHAM, T. (1993). The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine. Brain Res., 603, 186-200.
43. REISINE, T. & PASTERNAK, G. (1996). Opioid analgesic and antagonists. In The Pharmacological Basis of Therapeutics. ed. Hardman, J.G., Limbird, L.E., Molinof, P.B., Ruddon, R.W. & Goodman Gilman, A. pp. 521-555. New York: McGraw-Hill.
44. SANTIAGO, T.V. & NORMAN, H.E. (1985). Opioids and breathing. J. Appl. Physiol., 59, 1675-1685.
45. 2 receptor antagonist SR48968 inhibits thalamic responses evoked by thermal but not mechanical nociception. Eur. J. Pharmacol., 237, 143-146.
46. 2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), on autonomic outflow in the anaesthetized cat. Br. J. Pharmacol., 104, 367-372.
47. 1D receptor antagonist. Behav. Brain Res., 73, 157-161.
48. 1A agonists into the dorsal motor vagal nucleus produce a bradycardia in the atenolol-pretreated anaesthetized rat. Br. J. Pharmacol., 104, 467-470.
49. VAN DEN HOOGEN, R.H. & COLPAERT, F.C. (1986). Respiratory effects of morphine in awake unrestrained rats. J. Pharmacol. Exp. Ther., 237, 252-259.
50. WINER, B.J. (1971). Statistical Principles in Experimental Design. Second Edition. New York: McGraw-Hill.
51. ZARRINDAST, M.R., SAJEDIAN, M., REZAYAT, M. & GHAZIKHANSARI, M. (1995). Effects of 5-HT receptor antagonists on morphine-induced tolerance in mice. Eur. J. Pharmacol., 273, 203-207.